Webinar: Accelerated mRNA manufacturing from synthetic DNA templates

Applications of mRNA are expanding at a rapid pace, leading to a greater demand for reagents and suppliers who can enable production of high-quality vaccines and therapies. Production hurdles must be overcome to keep pace with the growing demand. In this free webinar, Dr. Seth Cheetham (BASE, University of Queensland) will discuss various mRNA applications and how BASE, Australia’s leading mRNA manufacturer, is tackling those challenges and continue to increase their production capabilities with workflow optimizations, such as synthetic templates.

What you’ll learn:

• Various applications of mRNA therapies
• Details of mRNA structure and workflows
• Manufacturing challenges and how to overcome them
• Tips for increased production

Speakers: 
Dr. Seth Cheetham, PhD - BASE Deputy Director, University of Queensland Group Leader, BASE mRNA facility, University of Queensland
Dr. Seth Cheetham is a group leader and ARC DECRA fellow at the Australian Institute for Bioengineering and Nanotechnology, University of Queensland. Seth is also the Deputy Director of the BASE mRNA facility, Australia’s leading mRNA manufacture and research site. He leads a research program that aims to progress a new class of mRNA therapeutics, targeting transcription factors for cancer therapy, to the clinic. Seth’s research has focused on RNA biology and transcription factors since his PhD at the University of Cambridge. He has authored more than 20 publications, in some of the most influential molecular biology journals.

Dr. Andrea Vyas, PhD (Moderator) - Product Manager, Synthetic Biology, Integrated DNA Technologies
Andrea Vyas is a Synthetic Biology Product Manager at Integrated DNA Technologies. Andrea completed her PhD in Molecular and Cellular Biology at the University of Iowa in 2019, at which time she joined IDT as a Synthetic Biology Application Scientist.

When: Wednesday, January 31st, 2024 at 17.00 CET 

Where: Online (free)

Register now!